Open original FDA record ↗Recall record
- FDA identifier
- Z-0576-2022
- Company in FDA record
- Baxter Healthcare Corporation
- FDA record creation date
- Feb 8, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Cleaning products, containing, but not limited to, hydrogen peroxide, bleach, alcohol, or antiseptic agents and solvent, such as those containing acetone, toluene, xylene, or cyclohexanone may cause damage, such as leaking or cracking, to the MiniCap Extended Life PD transfer sets.
Source facts
- Action
- Baxter disseminated a Urgent Medical Device Correction letter on 7 January 2022 to peritoneal dialysis centers and will follow with notice to the patients on 12 January 2022. The notices warned that the use of cleaning products and solvents may cause damage (for example, leaking or cracking), if they come into direct contact with the transfer set. Baxter will be updating the Instructions for Use (IFU) to include a warning against the use of these cleaning products and solvents. For general questions regarding this communication, contact Baxter Corporate Product Surveillance at 800-437-5176.
- Initiated
- 2022-01-07
- Root cause
- Other
- Distribution
- Worldwide
- Recall number
- Z-0576-2022
- Recall status
- Open, Classified
- CDRH record ID
- 191278
- FDA record created
- 2022-02-08
- Recall event number
- 89327